Improved methods for the detection of heme and protoporphyrin IX adducts and quantification of heme B from cytochrome P450 containing systems
- PMID: 37956555
- PMCID: PMC10842765
- DOI: 10.1016/j.jchromb.2023.123921
Improved methods for the detection of heme and protoporphyrin IX adducts and quantification of heme B from cytochrome P450 containing systems
Abstract
Heme B is a critical prosthetic group for the function of numerous proteins including the cytochrome P450 (CYP) family of enzymes. CYP enzymes are involved in the metabolism of endogenous and xenobiotic molecules that are of central interest in drug development. Formation of reactive metabolites by CYPs can lead to heme modification and destruction of the enzyme. The structure of the adducted heme can provide key information on the mechanism of inactivation, which is of great interest during preclinical drug discovery. Historically, techniques to extract the modified heme or protoporphyrin IX species involved harsh extraction conditions and esterification of propionate groups to aid chromatography. We have developed a simplified extraction method and LC/MS chromatography system that does not require derivatization to quantify heme B and identify modified heme B species from multiple CYP-containing matrices. The method uses mass defect filter triggered data dependent MS2 scans to rapidly identify heme and protoporphyrin IX adducts. These methods may also be useful for the analysis of other heme variants and hemoproteins.
Copyright © 2023 Elsevier B.V. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures








References
-
- Hemes in Biology, Wiley Encyclopedia of Chemical Biology, pp. 1–10.
-
- Ortiz de Montellano PR, Cytochrome P450 : structure, mechanism, and biochemistry, 4th edition. ed., Cham: : Springer, Cham, 2015.
-
- Kalgutkar A, Obach R, Maurer T, Mechanism-based inactivation of cytochrome P450 enzymes: Chemical mechanisms, structure-activity relationships and relationship to clinical drug-drug interactions and idiosyncratic adverse drug reactions, Curr. Drug Metab, 8 (2007) 407–447. - PubMed
-
- Tailor A, Waddington JC, Meng X, Park BK, Mass Spectrometric and Functional Aspects of Drug-Protein Conjugation, Chemical research in toxicology, 29 (2016) 1912–1935. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources